For instance, Li et al. demonstrated that HIF-1/2 regulates the tumorigenic capacity of glioma stem cells and showed that HIF-2α colocalizes with cancer stem cell markers [88]. This evidence concerns the gene EPAS1 and central nervous system cancer.